Literature DB >> 2789164

Intraocular non-Hodgkin's lymphoma treated with systemic and intrathecal chemotherapy and radiotherapy. A case report and review of the literature.

A J Rouwen1, P W Wijermans, T N Boen-Tan, J S Stilma.   

Abstract

A case of therapy-resistant bilateral intermediate uveitis is presented. Vitreous biopsy and lumbar puncture resulted in the diagnosis of high-grade malignant non-Hodgkin's lymphoma (NHL). Because chemotherapy and radiotherapy continue to yield better results in the treatment of NHL and a cure can be reached in a large group of patients with high-grade malignant NHL, early diagnosis is very important. We therefore recommend early vitreous biopsy in persistent, bilateral, granulomatous intermediate uveitis, especially in older patients. Our patient achieved a complete remission (follow-up period at the time of writing, 18 months after the beginning of polychemotherapy and radiotherapy). The chemotherapy modalities are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789164     DOI: 10.1007/bf02169412

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

1.  Intraocular reticulum cell sarcoma. Diagnosis by pars plana vitrectomy.

Authors:  R G Michels; D L Knox; Y S Erozan; W R Green
Journal:  Arch Ophthalmol       Date:  1975-12

2.  Vitreous cellular reaction. Association with reticulum cell sarcoma of brain.

Authors:  J S Kennerdell; B L Johnson; H M Wisotzkey
Journal:  Arch Ophthalmol       Date:  1975-12

3.  Infiltrative retinopathy in systemic lymphoma.

Authors:  R A Lewis; R B Clark
Journal:  Am J Ophthalmol       Date:  1975-01       Impact factor: 5.258

4.  Uveitis and reticulum cell sarcoma of brain with bilateral neoplastic seeding of vitreous without retinal or uveal involvement.

Authors:  D S Minckler; R L Font; L E Zimmerman
Journal:  Am J Ophthalmol       Date:  1975-09       Impact factor: 5.258

5.  Update of ocular reticulum cell sarcoma.

Authors:  H A Sloas; J Starling; D G Harper; H P Cupples
Journal:  Arch Ophthalmol       Date:  1981-06

6.  Intraocular reticulum-cell sarcoma: clinico-pathologic study of four cases and review of the literature.

Authors:  C C Barr; W R Green; J W Payne; D L Knox; A D Jensen; R L Thompson
Journal:  Surv Ophthalmol       Date:  1975 Jan-Feb       Impact factor: 6.048

7.  Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management.

Authors:  D H Char; B M Ljung; T Miller; T Phillips
Journal:  Ophthalmology       Date:  1988-05       Impact factor: 12.079

8.  B- and T-lymphocytes in ocular disease.

Authors:  F A Jakobiec; J Lefkowitch; D M Knowles
Journal:  Ophthalmology       Date:  1984-06       Impact factor: 12.079

9.  Ocular reticulum cell sarcoma. Clinicopathologic correlation of a case with multifocal lesions.

Authors:  G K Lang; J L Surer; W R Green; D Finkelstein; R G Michels; A E Maumenee
Journal:  Retina       Date:  1985 Spring-Summer       Impact factor: 4.256

10.  Ocular reticulum cell sarcoma.

Authors:  D H Char; L Margolis; A B Newman
Journal:  Am J Ophthalmol       Date:  1981-04       Impact factor: 5.258

View more
  3 in total

1.  Intraorbital lymphomas: neurosurgical experiences and management strategies.

Authors:  Nedal Hejazi
Journal:  Neurosurg Rev       Date:  2006-01-06       Impact factor: 3.042

2.  Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.

Authors:  M D de Smet; V S Vancs; D Kohler; D Solomon; C C Chan
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

3.  Toxicity of 1-(beta-D-arabinofuranosyl)cytosine after intravitreal injection in the rabbit eye.

Authors:  J J Diets-Ouwehand; R J de Keizer; G F Vrensen; S Groen-Jansen; J A van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.